The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.

J Clin Oncol · 2022 · PMC9553376 · PMID 35704792

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP < .00001actually significant

Comparing the proportion of stage I PDACs to the national average is highly significant; in 2016, 5.4% of 8,398 PDACs in the SEER database (National Cancer Institute-SEER) were stage I by surgical pathology ( P < .00001, Fisher's exact test). 3 Seven of the nine patients diagnosed with a screen-detected PDAC are alive, with median overall survival to date of 3.84 years.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.